Int. J. Mol. Sci. 2012, 13(11), 15271-15278; doi:10.3390/ijms131115271

Review
Role of Oxidative Stress in Hepatocarcinogenesis Induced by Hepatitis C Virus
Kyoko Tsukiyama-Kohara
Department of Animal Hygiene, Transboundary Animal Diseases Center, Joint Faculty of Veterinary Medicine Kagoshima University, 1-21-24 Korimoto, Kagoshima 890-0065, Japan; E-Mail: kkohara@agri.kagoshima-u.ac.jp; Tel./Fax: +81-99-285-3589
Received: 11 September 2012; in revised form: 8 November 2012 / Accepted: 9 November 2012 /
Published: 19 November 2012

Abstract

: Hepatitis C virus (HCV) easily establishes chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). During the progression of HCV infections, reactive oxygen species (ROS) are generated, and these ROS then induce significant DNA damage. The role of ROS in the pathogenesis of HCV infection is still not fully understood. Recently, we found that HCV induced the expression of 3β-hydroxysterol Δ24-reductase (DHCR24). We also found that a HCV responsive region is present in the 5′-flanking genomic promoter region of DHCR24 and the HCV responsive region was characterized as (−167/−140). Moreover, the transcription factor Sp1 was found to bind to this region in response to oxidative stress under the regulation of ataxia telangiectasia mutated (ATM) kinase. Overexpression of DHCR24 impaired p53 activity by suppression of acetylation and increased interaction with MDM2. This impairment of p53 suppressed the hydrogen peroxide-induced apoptotic response in hepatocytes. Thus, a target of oxidative stress in HCV infection is DHCR24 through Sp1, which suppresses apoptotic responses and increases tumorigenicity.
Keywords:
hepatitis C virus; reactive oxygen species; 3β-hydroxysterol Δ24-reductase

1. Introduction

Hepatitis C virus (HCV) is a member of the Flaviviridae family of RNA viruses, and possesses a positive-strand RNA genome [1]. HCV mainly replicates in the cytoplasm, but frequently establishes chronic infections, leading to the development of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) [2,3]. The estimated worldwide prevalence of HCV infections is 2.2%–3.0% [4], and chronic HCV infection is a major global public health concern. HCV does not possess canonical oncogenes and is unable to integrate into the host genome, but easily establishes chronic infections, resulting in HCC with high frequency. The exact mechanism by which this occurs is not fully understood; however, possible mediators of HCV pathogenesis are reactive oxygen species (ROS). During chronic hepatitis, the immune response induces the production of ROS [5] and nitric oxide (NO) [6]. Furthermore, HCV viral nucleocapsid protein, an HCV core protein, was shown to increase oxidative stress in the liver [7,8]. Moreover, HCV affects the steady-state levels of a mitochondrial protein chaperone known as prohibitin, leading to impaired function of the mitochondrial respiratory chain with the overproduction of ROS [9]. On the other hand, HCV compromises some of the antioxidant systems, including haeme oxygenase-1 [10] and NADH dehydrogenase quinone 1 [9], resulting in the provocation of oxidative stress in the liver during HCV infections. Thus, HCV infections not only induce ROS overproduction, but also hamper the antioxidant system in the liver. The induction of oxidative stress also results in the generation of deletions in mitochondrial and nuclear DNA, which are indicators of genetic damage. NO has been shown to induce oxidative DNA damage and inhibit DNA repair [1113]. These nucleotide abnormalities may contribute to the development of HCC [14].

2. Survey of HCV-Positive HCC-Related Host Factors

To define the host factors involved in hepatocarcinogenesis during HCV persistent infections, we established a human hepatoblastoma-derived cell line (HepG2), which expresses the full-length HCV genome under the control of a Cre/loxP system (RzM6 cells [15]). Using colony-formation assays and nude mice tumor-formation assays, we found that passaging of HCV-expressing cells (RzM6-LC cells) increased their tumorigenicity. To identify which pathway was responsible for the increase in tumorigenicity in RzM6-LC cells, we raised monoclonal antibodies against the RzM6-LC cells and characterized them [16]. We found that one of these clones (2-152a) recognizes 3β-hydroxysterol Δ24-reductase (or dehydrocholesterol reductase 24; DHCR24). DHCR24 functions as an enzyme that catalyzes the conversion of desmosterol to cholesterol in the post-squalene cholesterol biosynthesis pathway [17,18]. The absence of DHCR24 leads to desmosterosis [19]. Furthermore, expression of DHCR24 is down-regulated in areas of the brain affected by Alzheimer’s disease [20]. DHCR24 is a multifunctional enzyme, which exerts resistance against oxidative stress and prevents apoptotic cell death when it is expressed at high levels [2024]. Endogenous DHCR24/seladin-1 levels are up-regulated in response to acute oxidative stress [21,25,26], but the expression levels decline upon chronic exposure to oxidative stress [21,22]. DHCR24 is also reported to function as a hydrogen peroxide scavenger [24]. Thus, DHCR24 plays a crucial role in maintaining cellular physiology by regulating both cholesterol synthesis and cellular defence against oxidative stress, although the biological relevance of the hydrogen peroxide concentration (0.5–2 mM) used in some experiments requires future study.

3. HCV Induces DHCR24 Expression through Oxidative Stress

Since we observed up-regulation of DHCR24 expression in RzM6-LC cells, we decided to characterize the effects of HCV on DHCR24 expression [16,27]. Silencing of HCV by siRNA in RzM6-LC cells down-regulated the expression of DHCR24. By using chimeric mice with humanized liver [28], HCV infection induced the up-regulation of DHCR24 expression in human hepatocytes, whereas hepatitis B virus (HBV) infection had no significant effect on DHCR24 expression [16]. The regulation of DHCR24 expression was elicited at the transcriptional level. Therefore, we cloned the 5′-flanking region of the predicted genomic promoter region of DHCR24 (~5 kb) and characterized the promoter activity by construction of promoter reporter plasmids [27]. We transfected each HCV protein (core, E1, E2, NS2, NS3/4A, NS4B, NS5A, and NS5B) or the full-genome HCV. The full-genome HCV induced significantly higher DHCR24 expression than other HCV viral proteins. The serial deletion mutants of the 5′-flanking region of DHCR24 revealed that the minimum responsive element to the full-genome HCV was between −167 and −140 of the DHCR24 gene. An electronic mobility shift assay (EMSA) identified that the specific binding factor to this element was the Sp1 transcription factor.

Transcription of DHCR24 was induced by oxidative stress and impaired by the removal of the HCV minimum responsive element. Furthermore, the augmentation of DHCR24 expression was impaired by treatment with a ROS scavenger, N-acetylcysteine. We then explored the role of the Sp1 transcription factor in the regulation of DHCR24 expression. Phosphorylation of Sp1 at Ser101 was elevated under oxidative stress and increased by the presence of HCV. This phosphorylation of Sp1 was mediated through ataxia telangiectasia mutated (ATM) kinase [29,30]. Sustained phosphorylation of ATM and delayed de-phosphorylation of histone H2AX at Ser139 (γH2AX) were observed in HCV replicon cells [27,31], indicating that DNA repair was impaired in cells expressing or replicating HCV.

Previous studies revealed that expression of the HCV gene elevates the level of ROS via dysregulation of ER-mediated calcium homeostasis, which results in oxidative stress [32]. Also, the HCV core protein inhibits mitochondrial electron transport and increases ROS [33]. Recently, HCV infection is reported to increase ROS production through NADPH oxidase activity, especially elevated NADPH oxidase 4 (Nox4) [34]. The production of ROS can induce DHCR24 expression [27]. Thus, our results raised the possibility that DHCR24 plays a role in response to ROS generated as a consequence of HCV infection, thereby suppressing DNA repair and promoting tumorigenicity.

4. Overexpression of DHCR24 Results in Impairment of p53 Activity

HCV gene expression or infection persistently induces over-expression of DHCR24 [16,27] in its turn induces apoptotic resistance to oxidative stress (Figure 1).

HCV gene expression elevates the levels of ROS through dysregulation of ER-mediated calcium homeostasis. This increases the level of SP1 phosphorylation by ATM kinase, and results in the transcriptional activation of the DHCR24 gene. The augmentation of DHCR24 by HCV suppresses p53 activity by blocking nuclear p53 acetylation and increasing the interaction between p53 and HDM2 (p53-specific E3 ligase) in the cytoplasm, which may be mediated by inhibition of p53 degradation. This impairment of p53 activity may result in apoptotic resistance and increased tumorigenicity.

To further examine this mechanism, we characterized the regulatory proteins involved in the oxidative stress-induced apoptotic response and found that p53 activity was impaired in response to hydrogen peroxide, which was clarified by a p21WAF1/CIP1 promoter reporter assay. The post-translational modification of p53 after hydrogen peroxide treatment was characterized, and we found that the acetylation of p53 at Lys373 and Lys382 was impaired by the over-expression of DHCR24. The decreased level of p53 acetylation may impair p53 sequence-specific DNA-binding activity [35] and stability [36,37]. Moreover, interaction of p53 with its specific E3 ubiquitin ligase MDM2 (also known as HDM2) in the cytoplasm was augmented. These results strongly suggest that the increased interaction between p53 and MDM2, in the cytoplasm, impaired both the nuclear translocation and the activity of p53. This interaction between p53 and MDM2 was regulated by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase extracellular signal-regulated kinase (MEK-ERK)-induced phosphorylation at Ser166 in the MDM2 protein. Interestingly, MEK-ERK phosphorylation of MDM2 was liver specific [38].

5. Conclusion

The results of our studies showed a novel HCV-induced pathway that activates DHCR24 in response to oxidative stress. Overexpression of DHCR24 by HCV contributed to the development of HCC during persistent HCV infections. Recently, we found that silencing of DHCR24 by siRNA suppresses HCV replication [39] and an inhibitor of DHCR24 (U18666A) had an anti-viral effect in vivo. Monoclonal antibodies to DHCR24 (2-152a) suppress HCV replication through the betaine GABA transporter-1 (BGT-1) [40]. Thus, DHCR24 is involved in HCV replication and pathogenicity. DHCR24 catalyzes the reduction of the delta-24 bond of the sterol intermediate and works further downstream of farnesyl pyrophosphate, and therefore does not influence geranylgeranylation. Our findings may indicate the possible existence of a regulatory pathway of HCV replication by cholesterol synthesis and trafficking through DHCR24 in addition to protein geranylgeranylation. DHCR24 deficiency reduces cholesterol levels and disorganizes cholesterol-rich detergent-resistant membrane domains (DRMs) in mouse brains. Additionally, the HCV replication complex has been detected in the DRM fraction. Therefore, a deficiency in DRM, induced by silencing of DHCR24, may suppress HCV replication. In addition, BGT-1 plays a role in tonicity regulation and hyper-osmolarity [41], and recent reports show that hyperosmotic shrinkage stimulates duck hepatitis B virus replication [42]. BGT-1 is involved in sodium and chloride coupled betaine uptake and betaine levels affect lipid distribution even to such an extent that low plasma betaine levels correlate with unfavorable lipid profiles [43]. Future study will clarify the regulatory role of DHCR24 and BGT-1 in HCV replication.

In conclusion, the results of our studies suggest that HCV infected cells may become anti-apoptotic and replicate efficiently to establish chronic infection through over-expression of DHCR24. Thus, the HCV-induced oxidative stress responsive protein DHCR24 may play a critical role in the pathogenesis of HCV persistent infections.

Acknowledgements

The author is grateful to M. Saito, M. Satoh, T. Nishimura, Y. Kasama, and M. Kohara for their research and technical support. This work was supported by a grant from the Ministry of Health and Welfare as well as the Ministry of Science and Culture, Japan.

References

  1. Choo, Q.L.; Kuo, G.; Weiner, A.J.; Overby, L.R.; Bradley, D.W.; Houghton, M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244, 359–362.
  2. Jenny-Avital, E.R. Hepatitis C. Curr. Opin. Infect. Dis 1998, 11, 293–299.
  3. Saito, I.; Miyamura, T.; Ohbayashi, A.; Harada, H.; Katayama, T.; Kikuchi, S.; Watanabe, Y.; Koi, S.; Onji, M.; Ohta, Y.; et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 1990, 87, 6547–6549.
  4. Lavanchy, D. The global burden of hepatitis C. Liver Int 2009, 29, 74–81.
  5. Muriel, P. Role of free radicals in liver diseases. Hepatol. Int 2009, 3, 526–536.
  6. Garcia-Monzon, C.; Majano, P.L.; Zubia, I.; Sanz, P.; Apolinario, A.; Moreno-Otero, R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J. Hepatol 2000, 32, 331–338.
  7. Koike, K. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J. Gastroenterol. Hepatol 2007, 22, 108–111.
  8. Tardif, K.D.; Waris, G.; Siddiqui, A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol 2005, 13, 159–163.
  9. Fujinaga, H.; Tsutsumi, T.; Yotsuyanagi, H.; Moriya, K.; Koike, K. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology 2011, 81, 11–17.
  10. Zhu, Z.; Wilson, A.T.; Mathahs, M.M.; Wen, F.; Brown, K.E.; Luxon, B.A.; Schmidt, W.N. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 2008, 48, 1430–1439.
  11. Jaiswal, M.; LaRusso, N.F.; Shapiro, R.A.; Billiar, T.R.; Gores, G.J. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 2001, 120, 190–199.
  12. Machida, K.; McNamara, G.; Cheng, K.T.; Huang, J.; Wang, C.H.; Comai, L.; Ou, J.H.; Lai, M.M. Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. J. Immunol 2010, 185, 6985–6998.
  13. Machida, K.; Tsukamoto, H.; Liu, J.C.; Han, Y.P.; Govindarajan, S.; Lai, M.M.; Akira, S.; Ou, J.H. c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair. Hepatology 2010, 52, 480–492.
  14. Moriya, K.; Fujie, H.; Shintani, Y.; Yotsuyanagi, H.; Tsutsumi, T.; Ishibashi, K.; Matsuura, Y.; Kimura, S.; Miyamura, T.; Koike, K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med 1998, 4, 1065–1067.
  15. Tsukiyama-Kohara, K.; Tone, S.; Maruyama, I.; Inoue, K.; Katsume, A.; Nuriya, H.; Ohmori, H.; Ohkawa, J.; Taira, K.; Hoshikawa, Y.; et al. Activation of the CKI-CDK-Rb-E2F pathway in full genome hepatitis C virus-expressing cells. J. Biol. Chem 2004, 279, 14531–14541.
  16. Nishimura, T.; Kohara, M.; Izumi, K.; Kasama, Y.; Hirata, Y.; Huang, Y.; Shuda, M.; Mukaidani, C.; Takano, T.; Tokunaga, Y.; et al. Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase. J. Biol. Chem 2009, 284, 36442–36452.
  17. Crameri, A.; Biondi, E.; Kuehnle, K.; Lutjohann, D.; Thelen, K.M.; Perga, S.; Dotti, C.G.; Nitsch, R.M.; Ledesma, M.D.; Mohajeri, M.H. The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J 2006, 25, 432–443.
  18. Kedjouar, B.; De Medina, P.; Oulad-Abdelghani, M.; Payre, B.; Silvente-Poirot, S.; Favre, G.; Faye, J.C.; Poirot, M. Molecular characterization of the microsomal tamoxifen binding site. J. Biol. Chem 2004, 279, 34048–34061.
  19. Waterham, H.R.; Koster, J.; Romeijn, G.J.; Hennekam, R.C.; Vreken, P.; Andersson, H.C.; FitzPatrick, D.R.; Kelley, R.I.; Wanders, R.J. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet 2001, 69, 685–694.
  20. Greeve, I.; Hermans-Borgmeyer, I.; Brellinger, C.; Kasper, D.; Gomez-Isla, T.; Behl, C.; Levkau, B.; Nitsch, R.M. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer’s disease-associated neurodegeneration and oxidative stress. J. Neurosci 2000, 20, 7345–7352.
  21. Benvenuti, S.; Saccardi, R.; Luciani, P.; Urbani, S.; Deledda, C.; Cellai, I.; Francini, F.; Squecco, R.; Rosati, F.; Danza, G.; et al. Neuronal differentiation of human mesenchymal stem cells: Changes in the expression of the Alzheimer’s disease-related gene seladin-1. Exp. Cell Res 2006, 312, 2592–2604.
  22. Kuehnle, K.; Crameri, A.; Kalin, R.E.; Luciani, P.; Benvenuti, S.; Peri, A.; Ratti, F.; Rodolfo, M.; Kulic, L.; Heppner, F.L.; et al. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Mol. Cell. Biol 2008, 28, 539–550.
  23. Luciani, P.; Gelmini, S.; Ferrante, E.; Lania, A.; Benvenuti, S.; Baglioni, S.; Mantovani, G.; Cellai, I.; Ammannati, F.; Spada, A.; et al. Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab 2005, 90, 6156–6161.
  24. Lu, X.; Kambe, F.; Cao, X.; Kozaki, Y.; Kaji, T.; Ishii, T.; Seo, H. 3Beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 2008, 149, 3267–3273.
  25. Wu, C.; Miloslavskaya, I.; Demontis, S.; Maestro, R.; Galaktionov, K. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 2004, 432, 640–645.
  26. Di Stasi, D.; Vallacchi, V.; Campi, V.; Ranzani, T.; Daniotti, M.; Chiodini, E.; Fiorentini, S.; Greeve, I.; Prinetti, A.; Rivoltini, L.; et al. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis. Int. J. Cancer 2005, 115, 224–230.
  27. Saito, M.; Kohara, M.; Tsukiyama-Kohara, K. Hepatitis C virus promotes expression of the 3beta-hydroxysterol delta24-reductase through Sp1. J. Med. Virol 2012, 84, 733–746.
  28. Mercer, D.F.; Schiller, D.E.; Elliott, J.F.; Douglas, D.N.; Hao, C.; Rinfret, A.; Addison, W.R.; Fischer, K.P.; Churchill, T.A.; Lakey, J.R.; et al. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med 2001, 7, 927–933.
  29. Olofsson, B.A.; Kelly, C.M.; Kim, J.; Hornsby, S.M.; Azizkhan-Clifford, J. Phosphorylation of Sp1 in response to DNA damage by ataxia telangiectasia-mutated kinase. Mol. Cancer Res 2007, 5, 1319–1330.
  30. Iwahori, S.; Shirata, N.; Kawaguchi, Y.; Weller, S.K.; Sato, Y.; Kudoh, A.; Nakayama, S.; Isomura, H.; Tsurumi, T. Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein. J. Virol 2007, 81, 9653–9664.
  31. Lai, C.K.; Jeng, K.S.; Machida, K.; Cheng, Y.S.; Lai, M.M. Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation. Virology 2008, 370, 295–309.
  32. Gong, G.; Waris, G.; Tanveer, R.; Siddiqui, A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. USA 2001, 98, 9599–9604.
  33. Korenaga, M.; Wang, T.; Li, Y.; Showalter, L.A.; Chan, T.; Sun, J.; Weinman, S.A. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J. Biol. Chem 2005, 280, 37481–37488.
  34. De Mochel, N.S.; Seronello, S.; Wang, S.H.; Ito, C.; Zheng, J.X.; Liang, T.J.; Lambeth, J.D.; Choi, J. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 2010, 52, 47–59.
  35. Gu, W.; Roeder, R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997, 90, 595–606.
  36. Ito, A.; Lai, C.H.; Zhao, X.; Saito, S.; Hamilton, M.H.; Appella, E.; Yao, T.P. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 2001, 20, 1331–1340.
  37. Bonaccorsi, L.; Luciani, P.; Nesi, G.; Mannucci, E.; Deledda, C.; Dichiara, F.; Paglierani, M.; Rosati, F.; Masieri, L.; Serni, S.; et al. Androgen receptor regulation of the seladin-1/DHCR24 gene: Altered expression in prostate cancer. Lab. Invest 2008, 88, 1049–1056.
  38. Malmlof, M.; Roudier, E.; Hogberg, J.; Stenius, U. MEK-ERK-Mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 is activated in response to inhibited Akt signaling. J. Biol. Chem 2007, 282, 2288–2296.
  39. Takano, T.; Tsukiyama-Kohara, K.; Hayashi, M.; Hirata, Y.; Satoh, M.; Tokunaga, Y.; Tateno, C.; Hayashi, Y.; Hishima, T.; Funata, N.; et al. Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes. J. Hepatol 2011, 55, 512–521.
  40. Satoh, M.; Saito, M.; Takano, T.; Kasama, Y.; Nishimura, T.; Nishito, Y.; Hirata, Y.; Arai, M.; Sudoh, M.; Kai, C.; et al. Monoclonal antibody 2–152a suppresses hepatitis C virus infection through betaine/GABA transporter-1. J. Infect. Dis 2011, 204, 1172–1180.
  41. Takenaka, M.; Preston, A.S.; Kwon, H.M.; Handler, J.S. The tonicity-sensitive element that mediates increased transcription of the betaine transporter gene in response to hypertonic stress. J. Biol. Chem 1994, 269, 29379–29381.
  42. Offensperger, W.B.; Offensperger, S.; Stoll, B.; Gerok, W.; Haussinger, D. Effects of anisotonic exposure on duck hepatitis B virus replication. Hepatology 1994, 20, 1–7.
  43. Lever, M.; George, P.M.; Atkinson, W.; Molyneux, S.L.; Elmslie, J.L.; Slow, S.; Richards, A.M.; Chambers, S.T. Plasma lipids and betaine are related in an acute coronary syndrome cohort. PLoS One 2011, 6, e21666.
Ijms 13 15271f1 200
Figure 1. Elevation of tumorigenicity in HCV infected hepatocytes through increased oxidative stress and DHCR24.

Click here to enlarge figure

Figure 1. Elevation of tumorigenicity in HCV infected hepatocytes through increased oxidative stress and DHCR24.
Ijms 13 15271f1 1024
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert